Related Experiment Video

Updated: Apr 1, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

4.4K

Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated

Yue Zhao1, Yue Feng2, Yun-Mei Zhang3

  • 1Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, Kunming 650500, P.R. China.

International Journal of Molecular Medicine
|October 14, 2015
PubMed

Insights

Genetic mutations in dilated cardiomyopathy (DCM) were identified in over half of patients, revealing novel and known variants in sarcomere and cytoskeletal genes. This aids in clinical management and family risk prediction for DCM.

Area of Science:

  • Genetics and Molecular Biology
  • Cardiology
  • Genomic Medicine

Background:

  • Dilated cardiomyopathy (DCM) is a significant cause of heart failure and sudden cardiac death, often necessitating heart transplantation.
  • Genetic factors are strongly implicated in DCM, with over 50 associated genes currently documented.
  • The genetic and clinical heterogeneity of DCM presents challenges in diagnosis and prognosis.

Purpose of the Study:

  • To investigate the characteristics and prevalence of gene mutations in patients diagnosed with dilated cardiomyopathy.
  • To identify novel and known genetic variants associated with DCM.
  • To understand the distribution of mutations within specific gene categories (sarcomere and cytoskeletal).

Main Methods:

  • Utilized next-generation sequencing (NGS) to screen candidate DCM-associated genes.
  • Confirmed identified non-synonymous mutations using traditional capillary Sanger sequencing.
  • Analyzed a cohort of 21 patients with diagnosed DCM.

Main Results:

  • Identified possible causative non-synonymous mutations in approximately 57% (12/21) of DCM patients.
  • Discovered 7 novel mutations (e.g., MYPN p.E630K, TNNT2 p.G180A), 3 variants of uncertain significance, and 2 known mutations.
  • Found mutations predominantly in sarcomere (MYH6, MYBPC3, MYH7, TNNC1, TNNT2, MYL3) and cytoskeletal (MYPN, DES, VCL) genes.

Conclusions:

  • Genetic testing is a valuable tool for the clinical management of dilated cardiomyopathy.
  • Identification of pathogenic mutations can guide patient treatment strategies.
  • Genetic analysis aids in predicting disease risk for family members, enabling early intervention.

More Related Videos

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.5K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
84
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
765
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
718